Conclusions: TMEM25 in ccRCC could potentially function as a tumor suppressor gene, holding substantial promise as a novel biomarker for diagnosing, treating, and prognosticating ccRCC patients. Here, TMEM25 is linked to nonpapillary renal cell carcinoma.